Xiaohui Song
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xiaohui Song has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Ke Yao
Eye Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Key Laboratory of Ophthalmology, Zhejiang Provincial Clinical Research Center for Eye Diseases, Zhejiang Provincial Engineering Institute on Eye Diseases, Hangzhou, China
2 shared publications Qiao Jin
MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310058, PR China
2 shared publications- Beng Chin Ooi
Zhejiang University, Hangzhou, China
1 shared publication - Danni Lyu
Eye Center of the 2nd Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Key Lab of Ophthalmology, Hangzhou, China
1 shared publication - Haijie Han
Eye Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Key Laboratory of Ophthalmology, Zhejiang Provincial Clinical Research Center for Eye Diseases, Zhejiang Provincial Engineering Institute on Eye Diseases, Hangzhou, China
1 shared publication - Jia-Qian Liu
State Key Laboratory of Membrane Biology, School of Life Sciences, Tsinghua University, Beijing 100084, China
1 shared publication
Latest Publications
- Open Access
- 1 November 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 65, 506-520
Antioxidant and anti-senescence supramolecular complexes for managing dry eye diseases
Dry eye disease (DED) is a common ocular disorder that severely impairs daily life. Oxidative stress has been identified as a key pathogenic factor driving cellular senescence and corneal epithelial damage in DED. Herein, we developed a biocompatible supramolecular complex based on the host-guest interaction of TEMPO-modified β-cyclodextrin (TCD) and puerarin (Pue), designated as P@TCD, for managing DED. The P@TCD could mitigate the ROS accumulation, reduce DNA damage, promote cell cycle progression, and attenuate cellular senescence in the corneal epithelium, thus preventing the further deterioration of DED. In two DED mouse models, P@TCD demonstrated favorable therapeutic efficacy by reversing corneal epithelial defects, alleviating conjunctival damage, and accelerating lacrimal gland recovery, thereby restoring tear film homeostasis, especially improving tear film stability with TBUT values of more than 5.3 s, compared to the DED models of less than 2.8 s, which is even more than the Cycloome® of 3.7 s. These results suggested the considerable potential of this dual ROS scavenging strategy for the effective treatment of DED.
- 1 November 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 65, 506-520
Open AccessAntioxidant and anti-senescence supramolecular complexes for managing dry eye diseases
Dry eye disease (DED) is a common ocular disorder that severely impairs daily life. Oxidative stress has been identified as a key pathogenic factor driving cellular senescence and corneal epithelial damage in DED. Herein, we developed a biocompatible supramolecular complex based on the host-guest interaction of TEMPO-modified β-cyclodextrin (TCD) and puerarin (Pue), designated as P@TCD, for managing DED. The P@TCD could mitigate the ROS accumulation, reduce DNA damage, promote cell cycle progression, and attenuate cellular senescence in the corneal epithelium, thus preventing the further deterioration of DED. In two DED mouse models, P@TCD demonstrated favorable therapeutic efficacy by reversing corneal epithelial defects, alleviating conjunctival damage, and accelerating lacrimal gland recovery, thereby restoring tear film homeostasis, especially improving tear film stability with TBUT values of more than 5.3 s, compared to the DED models of less than 2.8 s, which is even more than the Cycloome® of 3.7 s. These results suggested the considerable potential of this dual ROS scavenging strategy for the effective treatment of DED.
- Open Access
- 7 August 2026
- Published by Elsevier in SSRN Electronic Journal
Zinc–Sodium Lignosulfonate Metal–Phenolic Nanocomplexes for the Treatment of Infectious Keratitis by MRSA Eradication and Inflammation Alleviation
Methicillin-resistant Staphylococcus aureus (MRSA)-induced keratitis remains a formidable clinical challenge, where persistent biofilms and excessive host inflammation synergistically compromise corneal integrity. Herein, multifunctional zinc–sodium lignosulfonate (SLS) metal–phenolic nanocomplexes (ZS MPNs) are synthesized by the one-pot coordination self-assembly of zinc ions and SLS. ZS MPNs integrate the bioadhesive and radical-scavenging properties of SLS with the potent antimicrobial activity of zinc ions. ZS MPNs achieve adhesion-mediated MRSA eradication and biofilm collapse, with transcriptomic analyses revealing localized metal-ion stress that disrupts bacterial membranes and virulence pathways. Importantly, ZS MPNs mitigate the cytotoxicity of free Zn2+, restore host redox balance by scavenging ROS, and repolarize macrophages toward a pro-resolving M2 phenotype. In a murine MRSA-induced keratitis model, topical ZS MPNs exhibit prolonged ocular retention, nearly complete bacterial clearance, and protection against stromal degradation by suppressing NF-κB-related inflammatory signaling and neutrophil-driven matrix melting. The therapeutic efficacy of ZS MPNs is further validated in MRSA-infected dermal wounds, accompanied by favorable in vivo biosafety. This work suggests that ZS MPNs may provide a sustainable, non-antibiotic topical strategy that couples localized MRSA killing with immune microenvironment remodeling for corneal tissue preservation.
- 7 August 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessZinc–Sodium Lignosulfonate Metal–Phenolic Nanocomplexes for the Treatment of Infectious Keratitis by MRSA Eradication and Inflammation Alleviation
Methicillin-resistant Staphylococcus aureus (MRSA)-induced keratitis remains a formidable clinical challenge, where persistent biofilms and excessive host inflammation synergistically compromise corneal integrity. Herein, multifunctional zinc–sodium lignosulfonate (SLS) metal–phenolic nanocomplexes (ZS MPNs) are synthesized by the one-pot coordination self-assembly of zinc ions and SLS. ZS MPNs integrate the bioadhesive and radical-scavenging properties of SLS with the potent antimicrobial activity of zinc ions. ZS MPNs achieve adhesion-mediated MRSA eradication and biofilm collapse, with transcriptomic analyses revealing localized metal-ion stress that disrupts bacterial membranes and virulence pathways. Importantly, ZS MPNs mitigate the cytotoxicity of free Zn2+, restore host redox balance by scavenging ROS, and repolarize macrophages toward a pro-resolving M2 phenotype. In a murine MRSA-induced keratitis model, topical ZS MPNs exhibit prolonged ocular retention, nearly complete bacterial clearance, and protection against stromal degradation by suppressing NF-κB-related inflammatory signaling and neutrophil-driven matrix melting. The therapeutic efficacy of ZS MPNs is further validated in MRSA-infected dermal wounds, accompanied by favorable in vivo biosafety. This work suggests that ZS MPNs may provide a sustainable, non-antibiotic topical strategy that couples localized MRSA killing with immune microenvironment remodeling for corneal tissue preservation.
- Open Access
- 27 October 2025
- Published by Association for Computing Machinery (ACM)
- p. 3893-3902
EyecareGPT: Boosting Comprehensive Ophthalmology Understanding with Tailored Dataset, Benchmark and Model
- 27 October 2025
- Published by Association for Computing Machinery (ACM)
- p. 3893-3902
Open AccessEyecareGPT: Boosting Comprehensive Ophthalmology Understanding with Tailored Dataset, Benchmark and Model
- Open Access
Human Ccr4 and Caf1 Deadenylases Regulate Proliferation and Tumorigenicity of Human Gastric Cancer Cells via Modulating Cell Cycle Progression
Cancer cells generally have reprogrammed gene expression profiles to meet the requirements of survival, continuous division, and metastasis. An interesting question is whether the cancer cells will be affected by interfering their global RNA metabolism. In this research, we found that human Ccr4a/b (hCcr4a/b) and Caf1a/b (hCaf1a/b) deadenylases, the catalytic components of the Ccr4-Not complex, were dysregulated in several types of cancers including stomach adenocarcinoma. The impacts of the four deadenylases on cancer cell growth were studied by the establishment of four stable MKN28 cell lines with the knockdown of hCcr4a/b or hCaf1a/b or transient knockdown in several cell lines. Depletion of hCcr4a/b or hCaf1a/b significantly inhibited cell proliferation and tumorigenicity. Mechanistic studies indicated that the cells were arrested at the G2/M phase by knocking down hCaf1a, while arrested at the G0/G1 phase by depleting hCaf1b or hCcr4a/b. The four enzymes did not affect the levels of CDKs and cyclins but modulated the levels of CDK–cyclin inhibitors. We identified that hCcr4a/b, but not hCaf1a/b, targeted the p21 mRNA in the MKN28 cells. Furthermore, depletion of any one of the four deadenylases dramatically impaired processing-body formation in the MKN28 and HEK-293T cells. Our results highlight that perturbating global RNA metabolism may severely affect cancer cell proliferation, which provides a potential novel strategy for cancer treatment.
Open AccessHuman Ccr4 and Caf1 Deadenylases Regulate Proliferation and Tumorigenicity of Human Gastric Cancer Cells via Modulating Cell Cycle Progression
Cancer cells generally have reprogrammed gene expression profiles to meet the requirements of survival, continuous division, and metastasis. An interesting question is whether the cancer cells will be affected by interfering their global RNA metabolism. In this research, we found that human Ccr4a/b (hCcr4a/b) and Caf1a/b (hCaf1a/b) deadenylases, the catalytic components of the Ccr4-Not complex, were dysregulated in several types of cancers including stomach adenocarcinoma. The impacts of the four deadenylases on cancer cell growth were studied by the establishment of four stable MKN28 cell lines with the knockdown of hCcr4a/b or hCaf1a/b or transient knockdown in several cell lines. Depletion of hCcr4a/b or hCaf1a/b significantly inhibited cell proliferation and tumorigenicity. Mechanistic studies indicated that the cells were arrested at the G2/M phase by knocking down hCaf1a, while arrested at the G0/G1 phase by depleting hCaf1b or hCcr4a/b. The four enzymes did not affect the levels of CDKs and cyclins but modulated the levels of CDK–cyclin inhibitors. We identified that hCcr4a/b, but not hCaf1a/b, targeted the p21 mRNA in the MKN28 cells. Furthermore, depletion of any one of the four deadenylases dramatically impaired processing-body formation in the MKN28 and HEK-293T cells. Our results highlight that perturbating global RNA metabolism may severely affect cancer cell proliferation, which provides a potential novel strategy for cancer treatment.
- Open Access
- 23 September 2019
- Published by Wiley in Journal of Ophthalmology
- Vol. 2019, 1-9
Comparison of the Clinical Outcomes between Echelette Extended Range of Vision and Diffractive Bifocal Intraocular Lenses
Purpose. To compare the clinical outcomes of echelette extended range of vision (ERV) and diffractive bifocal intraocular lenses (IOLs). Methods. This is a prospective, consecutive, nonrandomized clinical trial. Seventy-three eligible patients (109 eyes) received the implantation of echelette ERV IOL (Tecnis Symfony ZXR00) or diffractive bifocal IOL (Tecnis ZMB00). 1 week, 1 month, and 3 months after surgery, visual acuities at different distances were examined. At 3 months, defocus curves, contrast sensitivities (CSs) with and without glare, optic path difference (OPD) scans, and questionnaires were evaluated. Regression analyses were applied to discover influence factors on postoperative vision. Results. ZXR00 showed better distance () and intermediate () visual acuities, while ZMB00 was better at distance-corrected near visual acuity (). Multivariate analyses indicated that worse intermediate () and near vision () of ZMB00 might occur in patients with longer axial length. ZXR00 demonstrated smoother defocus curve and higher CSs. Superior modulation transfer function (MTF) and higher Strehl ratio () were shown in ZXR00. In questionnaire evaluation, ZXR00 received better outcomes in self-reported vision, Visual Function-14 (VF-14) questionnaire, Quality of Vision (QoV) questionnaire, satisfaction, and recommendation grades. Spectacle dependence did not differ between ZXR00 and ZMB00 statistically. Conclusion. ZXR00 proved to be remarkable in distance and intermediate vision, defocus curve smoothness, CSs, and visual comfort, while ZMB00 achieved better near vision. ZXR00 may attain better near vision if postoperative SE remains slightly negative. Patients with relatively longer axial length might receive less favorable intermediate and near vision after ZMB00 implantation. This trial is registered with ChiCTR-ONC-17011119.- 23 September 2019
- Published by Wiley in Journal of Ophthalmology
- Vol. 2019, 1-9
Open AccessComparison of the Clinical Outcomes between Echelette Extended Range of Vision and Diffractive Bifocal Intraocular Lenses
Purpose. To compare the clinical outcomes of echelette extended range of vision (ERV) and diffractive bifocal intraocular lenses (IOLs). Methods. This is a prospective, consecutive, nonrandomized clinical trial. Seventy-three eligible patients (109 eyes) received the implantation of echelette ERV IOL (Tecnis Symfony ZXR00) or diffractive bifocal IOL (Tecnis ZMB00). 1 week, 1 month, and 3 months after surgery, visual acuities at different distances were examined. At 3 months, defocus curves, contrast sensitivities (CSs) with and without glare, optic path difference (OPD) scans, and questionnaires were evaluated. Regression analyses were applied to discover influence factors on postoperative vision. Results. ZXR00 showed better distance () and intermediate () visual acuities, while ZMB00 was better at distance-corrected near visual acuity (). Multivariate analyses indicated that worse intermediate () and near vision () of ZMB00 might occur in patients with longer axial length. ZXR00 demonstrated smoother defocus curve and higher CSs. Superior modulation transfer function (MTF) and higher Strehl ratio () were shown in ZXR00. In questionnaire evaluation, ZXR00 received better outcomes in self-reported vision, Visual Function-14 (VF-14) questionnaire, Quality of Vision (QoV) questionnaire, satisfaction, and recommendation grades. Spectacle dependence did not differ between ZXR00 and ZMB00 statistically. Conclusion. ZXR00 proved to be remarkable in distance and intermediate vision, defocus curve smoothness, CSs, and visual comfort, while ZMB00 achieved better near vision. ZXR00 may attain better near vision if postoperative SE remains slightly negative. Patients with relatively longer axial length might receive less favorable intermediate and near vision after ZMB00 implantation. This trial is registered with ChiCTR-ONC-17011119.